Global Markets
Home›Global Markets›Europe›Weight-loss drugs may be tested for overweight cats
Weight-loss drugs may be tested for overweight cats
Companies are exploring GLP-1 based treatments for pets as pet owners shift spending toward animal health and longevity products.
CNBC World reports that startups are testing GLP-1 treatments for overweight cats, a move that mirrors the growing interest in weight-management drugs for humans.
The outlet also notes that major pet-food companies are increasingly leaning into longevity related products, reflecting how consumer spending is shifting toward animal health.
As owners spend more on wellness for their pets, the effort to develop and market weight-loss and longevity options is gaining momentum across the pet industry, according to CNBC World.
← Newer storyNifty and Sensex rise as bank and Reliance strength lifts India marke…Older story →Homeplus shuts all stores after suspending outlets and restructuring